FDA inspection
Biocon Limited: FDA inspection ending Jul 20, 2022
FDA inspection 1176477 · Official Action Indicated (OAI) · Pashamylaram
Key facts
| Inspection ID | 1176477 |
|---|---|
| Firm | Biocon Limited |
| FEI number | 3004956855 |
| Address | 216/B Plot No 213 - 215, Phase-Ii Ida |
| City | Pashamylaram |
| Fiscal year | 2022 |
| Inspection end date | Jul 20, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data